No Data
Wall Street Trims Ratings for Novo Nordisk Stock, as Ozempic's Competition Grows -- Barrons.com
Catalyst Watch: Spotlight on Tesla, Alphabet Earnings, AACR Drug Data, and Global PMI Reports
Eli Lilly Rallies Over 14%, Notches Best Day Since June 2000 On Oral Weight-Loss Drug Results: Analysts React
SA Asks: What's the Best Weight-loss Drug Stock Right Now?
Dow's 379-Point Drop Led By Losses For UnitedHealth, NVIDIA Corp. Shares
Express News | Shares of Some Obesity Drug Developers Fall After Eli Lilly's Pill Leads to Weight Loss in Late-Stage Trial